Drugs / Gingke biloba
last change Dec 2022 re-read 2 minutes ago

Gingke biloba

Developed for
schizophrenia
Investigated by
Shanghai Mental Health Center

Trials 1 · a red edge is where a trial was stopped

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04528095 Dec 2020 → Dec 2022 schizophrenia Shanghai Mental Health Center Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Gingke biloba Gingke biloba 120-360mg/d” NCT04528095